Pyxis Oncology company information, Employees & Contact Information

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets Yahoo Finance

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire

Cancer ADC Developer Pyxis Oncology Leadership to Share Updates at Major September Conferences Stock Titan

Pyxis Oncology Grants Stock Options to New Employees Under 2022 Inducement Plan Quiver Quantitative

Pyxis Oncology to Participate in September Investor and Industry Conferences GlobeNewswire

Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update Yahoo Finance

Pyxis Oncology Awards $1.10 Stock Options to Key New Hires - See Grant Details Stock Titan

Pyxis Oncology Prioritizes Development of Lead Asset PYX-201 Following Promising Phase 1 Results Nasdaq

Pyxis Oncology to Participate in Two Upcoming Investor Conferences Yahoo Finance

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets Quiver Quantitative

Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire

Pyxis Oncology Highlights Promising Preclinical Data for Micvotabart Pelidotin (MICVO) in Cancer Therapy at AACR 2025 Nasdaq

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC Yahoo Finance

Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer Yahoo Finance

Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data Yahoo Finance

Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 Yahoo Finance

Pyxis Oncology to Acquire Apexigen Yahoo Finance

FDA Grants Fast Track Designation to PYX-201 for Recurrent/Metastatic HNSCC OncLive

Pyxis Oncology to Present Translational Data and Key GlobeNewswire

382,518 Stock Options: Pyxis Oncology Awards Major Inducement Grants to New Cancer Drug Development Team Stock Titan

Pyxis Oncology Reports Promising Phase 1 Data for MICVO in Head and Neck Cancer, Receives FDA Fast Track Designation Nasdaq

First-in-Concept ADC Micvotabart Pelidotin Shows Early Antitumor Activity in HNSCC OncLive

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets Stock Titan

Pyxis Oncology Successfully Completes Acquisition of Apexigen Yahoo Finance

ctDNA reduction in 37 clinical samples: Pyxis Oncology presents MICVO translational findings at ESMO & AACR 2025 Stock Titan

FDA Grants Orphan Drug Designation to PYX-201 in Pancreatic Cancer Targeted Oncology

Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer PR Newswire

PYX-201 Receives Orphan Drug Designation From the FDA in Pancreatic Cancer OncLive

Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics GlobeNewswire

Pyxis Announces Pricing of Upsized Initial Public Offering GlobeNewswire

Pyxis Oncology Appoints Pamela Yanchik Connealy as Chief Financial Officer citybiz

Pyxis Oncology Presents Preclinical Data and Details on GlobeNewswire

PYXS Stock Price and Chart — NASDAQ:PYXS TradingView

Pyxis Oncology (PYXS) Stock Price, News & Analysis MarketBeat

PYXS - Pyxis Oncology, Inc. Latest Stock News & Market Updates Stock Titan